Prague Med. Rep. 2018, 119, 30-42
https://doi.org/10.14712/23362936.2018.3
Evaluation of IFN-γ Enzyme-linked Immunospot Assay (ELISPOT) as a First-line Test in the Diagnosis of Non-Immediate Hypersensitivity to Amoxicillin and Penicillin
References
1. 2006) Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J. Allergy Clin. Immunol. 117(2), 455–462.
< , A., Engler, O., Gerber, B. O., Pichler, W. J. (https://doi.org/10.1016/j.jaci.2005.10.030>
2. 2015) Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibiotics. J. Dermatol. Sci. 80(1), 71–74.
< , B., Arnaud-Butel, S., Rozières, A., Rodet, K., Bérard, F., Nicolas, J. F., Nosbaum, A. (https://doi.org/10.1016/j.jdermsci.2015.07.014>
3. 2009) Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 64, 183–193.
< , M., Romano, A., Torres, M. J., Férnandez, J., Mayorga, C., Rodriguez, J., Demoly, P., Bousquet, P. J., Merk, H. F., Sanz, M. L., Ott, H., Atanaskovic-Markovic, M. (https://doi.org/10.1111/j.1398-9995.2008.01924.x>
4. 2013) Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 68(6), 702–712.
< , K., Garvey, L. H., Aberer, W., Atanaskovic-Markovic, M., Barbaud, A., Bilo, M. B., Bircher, A., Blanca, M., Bonadonna, B., Campi, P., Castro, E., Cernadas, J. R., Chiriac, A. M., Demoly, P., Grosber, M., Gooi, J., Lombardo, C., Mertes, P. M., Mosbech, H., Nasser, S., Pagani, M., Ring, J., Romano, A., Scherer, K., Schnyder, B., Testi, S., Torres, M., Trautmann, A., Terreehorst, I.; ENDA/EAACI Drug Allergy Interest Group (https://doi.org/10.1111/all.12142>
5. 2014) International Consensus on drug allergy. Allergy 69, 420–437.
< , P., Adkinson, N. F., Brockow, K., Castells, M., Chiriac, A. M., Greenberger, P. A., Khan, D. A., Lang, D. M., Park, H. S., Pichler, W., Sanchez-Borges, M., Shiohara, T., Thong, B. Y. (https://doi.org/10.1111/all.12350>
6. 2011) The in vitro diagnosis of drug allergy: status and perspectives. Allergy 66, 1275–1286.
< , D. G., Leysen, J., Mayorga, C., Rozieres, A., Knol, E. F., Terreehorst, I. (https://doi.org/10.1111/j.1398-9995.2011.02661.x>
7. 2012) Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis. J. Pharmacol. Exp. Ther. 341(3), 597–610.
< , S., Monshi, M. M., Whitaker, P., Jenkins, R., Meng, X., Farrell, J., Elsheikh, A., Peckham, D., French, N., Pirmohamed, M., Park, B. K., Naisbitt, D. J. (https://doi.org/10.1124/jpet.111.190900>
<PubMed>
8. 2012) Detection of abacavir hypersensitivity by ELISpot method. Inflamm. Allergy Drug Targets 11(3), 227–234.
< , S., Jablonka, R., Heinemann, F. M., Reuter, S., Jaeger, H., von Krosigk, A., Schenk-Westkamp, P., Schadendorf, D., Horn, P. A., Lindemann, M. (https://doi.org/10.2174/187152812800392751>
9. 2009) Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy 64(2), 242–248.
< , T. D., Torres, M. J., Blanca-López, N., Rodríguez-Bada, J. L., Gomez, E., Canto, G., Mayorga, C., Blanca, M. (https://doi.org/10.1111/j.1398-9995.2008.01713.x>
10. 2012) Recovered patients with Stevens-Johnson syndrome and toxic epidermal necrolysis maintain long-lived IFN-γ and sFasL memory response. PLoS One 7(9), e45516.
< , M., Gao, Y., Pan, Y., Li, W., Liao, W., Wang, G., Li, C., Li, C., Gao, T., Liu, Y. (https://doi.org/10.1371/journal.pone.0045516>
<PubMed>
11. 2017) Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits. J. Dermatol. Sci. 86(3), 222–229.
< , K., Kawase, A., Azukizawa, H., Hanafusa, T., Nakagawa, Y., Murota, H., Sakaguchi, S., Asada, H., Katayama, I. (https://doi.org/10.1016/j.jdermsci.2017.03.007>
12. 2008) Cytokine expression profile of sensitized human T lymphocytes following in vitro stimulation with amoxicillin. Eur. Cytokine Netw. 19(3), 131–141.
, G., El-Sabban, M., Al-Ghadban, S., Azzi, S., Shamra, S., Khalifé, S., Maroun, R. (
13. 2014) Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J. Allergy Clin. Immunol. 133, 790–796.
< , E., Contreras, R. (https://doi.org/10.1016/j.jaci.2013.09.021>
14. 2016) In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 71, 1103–1134.
< , C., Celik, G., Rouzaire, P., Whitaker, P., Bonadonna, P., Rodrigues-Cernadas, J., Vultaggio, A., Brockow, K., Caubet, J. C., Makowska, J., Nakonechna, A., Romano, A., Montanez, M. I., Laguna, J. J., Zanoni, G., Gueant, J. L., Oude Elberink, H., Fernandez, J., Viel, S., Demoly, P., Torres, M. J.; In vitro tests for Drug Allergy Task Force of EAACI Drug Interest Group (https://doi.org/10.1111/all.12886>
15. 2013) In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions. Br. J. Dermatol. 168(3), 539–549.
< , M. E., Belgi, G., McGuire, C., Pickard, C., Healy, E., Friedmann, P. S., Ardern-Jones, M. R. (https://doi.org/10.1111/bjd.12109>
16. 2015) Drug-specific in vitro secretion of IFNγ in the diagnosis of drug-induced exanthemas: electrochemiluminiscence assay versus previously used diagnostic methods. Przegl. Lek. 72(12), 721–724.
, G., Czarnobilska, E. (
17. 2004) Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 59(11), 1153–1160.
< , A., Blanca, M., Torres, M. J., Bircher, A., Aberer, W., Brockow, K., Pichler, W. J., Demoly, P. (https://doi.org/10.1111/j.1398-9995.2004.00678.x>
18. 2009) Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 64(4), 534–542.
< , A., Hennino, A., Rodet, K., Gutowski, M. C., Gunera-Saad, N., Berard, F., Cozon, G., Bienvenu, J., Nicolas, J. F. (https://doi.org/10.1111/j.1398-9995.2008.01674.x>
19. 2014) Penicillin allergy as a public health measure. J. Allergy Clin. Immunol. 133, 797–798.
< , R. (https://doi.org/10.1016/j.jaci.2013.10.032>
20. 2013) The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems. Acta Derm. Venereol. 93(1), 66–69.
< , B., Buranapraditkun, S., Klaewsongkram, J. (https://doi.org/10.2340/00015555-1386>
21. 2016) The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid. Clin. Exp. Allergy 46, 264–274.
< , M. J., Montanez, M. I., Ariza, A., Salas, M., Fernandez, T. D., Berbero, N., Mayorga, C., Blanca, M. (https://doi.org/10.1111/cea.12689>
22. Trubiano, J. A., Strautins, K., Redwood, A. J., Pavlos, R., Konvinse, K. C., Aung, A. K., Slavin, M. A., Thursky, K. A., Grayson, M. L., Phillips, E. J. (2017) The combined utility of ex vivo IFN-γ release enzyme-linked immunoSpot assay and in vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions. J. Allergy Clin. Immunol. Pract. (Epub ahead of print)
23. 2010) In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases. Allergy 65(3), 376–384.
< , A., Lochmatter, P., Yerly, D., Kawabata, T., Lerch, M., Yawalkar, N., Pichler, W. J. (https://doi.org/10.1111/j.1398-9995.2009.02180.x>